I know I won’t be popular for saying this, but I
Post# of 72440
Quote:
In September 2018, the Company plans to submit a request to FDA for an End-of-Phase 2 meeting.
Since B-OM has Fast Track, I’m hoping the FDA agrees to meet within 30 days. If it happens in October, we can get a BTD decision in December.